경막 대체물 시장 : 시장 기회, 성장 촉진요인, 산업 동향 분석, 예측(2025-2034년)

The Global Dura Substitutes Market reached USD 214.2 million in 2024 and is projected to experience robust growth at a compound annual growth rate (CAGR) of 5.4% from 2025 to 2034. This growth trajectory is propelled by ongoing advancements in medical technologies, the increasing preference for minimally invasive procedures, rising awareness of neurosurgical treatments, and the expanding aging population. Collectively, these factors are driving the adoption of Dura substitutes in various medical applications.

Innovations in biomaterials and surgical techniques are significantly enhancing the performance and quality of dura substitutes. Modern materials, designed for improved biocompatibility, durability, and absorbability, are elevating surgical outcomes and solidifying the role of dura substitutes as essential components in neurosurgical practices. As medical technology continues to evolve, the demand for advanced dura substitutes is poised to rise, further accelerating market growth.

By product type, the market is categorized into biological and synthetic dura substitutes. Biological dura substitutes, derived from natural sources like collagen and animal tissues, are anticipated to grow at a CAGR of 5.1%, reaching USD 232.6 million by 2034. These substitutes offer exceptional biocompatibility and reduce risks associated with immune responses or rejection, making them a preferred choice for procedures requiring long-term tissue repair. Their seamless integration with the body ensures consistent demand and establishes them as a reliable solution in surgical applications.

The market is also segmented by application, including neurosurgery, spinal surgery, trauma and accident repairs, post-surgical repair, and others. The neurosurgery segment is expected to register significant growth with a projected CAGR of 5.5%, reaching USD 155.9 million by 2034. The increasing prevalence of neurological disorders and age-related conditions, coupled with the growing frequency of neurosurgical procedures, is driving demand for highly durable and effective dura substitutes. These materials are indispensable for repairing dura mater, reinforcing their critical role in neurosurgical treatments.

The U.S. Dura substitutes market, valued at USD 77 million in 2024, is forecasted to grow at a CAGR of 5% through 2034. The country's advanced healthcare infrastructure, combined with ongoing innovations in neurosurgical methods, including minimally invasive techniques, is fueling the adoption of high-performance, biocompatible substitutes. These advancements are enabling improved surgical outcomes and faster patient recovery, further supporting market expansion in the region.

Table of Contents

Chapter 1 Methodology and Scope

• 1.1 Market scope and definitions
• 1.2 Research design
  • 1.2.1 Research approach
  • 1.2.2 Data collection methods
• 1.3 Base estimates and calculations
  • 1.3.1 Base year calculation
  • 1.3.2 Key trends for market estimation
• 1.4 Forecast model
• 1.5 Primary research and validation
  • 1.5.1 Primary sources
  • 1.5.2 Data mining sources

Chapter 2 Executive Summary

• 2.1 Industry 360⁰ synopsis

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Increasing prevalence of neurological disorders
    • 3.2.1.2 Advancements in surgical techniques
    • 3.2.1.3 Increasing surgical awareness and adoption
    • 3.2.1.4 Rising demand for minimally invasive procedures
  • 3.2.2 Industry pitfalls and challenges
    • 3.2.2.1 High cost of dura substitutes
    • 3.2.2.2 Limited product availability in emerging markets
• 3.3 Growth potential analysis
• 3.4 Regulatory landscape
• 3.5 Technology landscape
• 3.6 Gap analysis
• 3.7 Porter's analysis
• 3.8 PESTEL analysis
• 3.9 Future market trends
• 3.10 Value chain analysis

Chapter 4 Competitive Landscape, 2024

• 4.1 Introduction
• 4.2 Company matrix analysis
• 4.3 Company market share analysis
• 4.4 Competitive analysis of major market players
• 4.5 Competitive positioning matrix
• 4.6 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Product Type, 2021 – 2034 ($ Mn)

• 5.1 Key trends
• 5.2 Biological dura substitute
• 5.3 Synthetic dura substitute

Chapter 6 Market Estimates and Forecast, By Material, 2021 – 2034 ($ Mn)

• 6.1 Key trends
• 6.2 Collagen-based
• 6.3 Polymers
• 6.4 Other materials

Chapter 7 Market Estimates and Forecast, By Application, 2021 – 2034 ($ Mn)

• 7.1 Key trends
• 7.2 Neurosurgery
• 7.3 Spinal surgery
• 7.4 Trauma/accident
• 7.5 Post-surgical repair
• 7.6 Other applications

Chapter 8 Market Estimates and Forecast, By End Use, 2021 – 2034 ($ Mn)

• 8.1 Key trends
• 8.2 Hospitals
• 8.3 Ambulatory surgical centers
• 8.4 Other end users

Chapter 9 Market Estimates and Forecast, By Region, 2021 – 2034 ($ Mn)

• 9.1 Key trends
• 9.2 North America
  • 9.2.1 U.S.
  • 9.2.2 Canada
• 9.3 Europe
  • 9.3.1 Germany
  • 9.3.2 UK
  • 9.3.3 France
  • 9.3.4 Spain
  • 9.3.5 Italy
  • 9.3.6 Netherlands
• 9.4 Asia Pacific
  • 9.4.1 China
  • 9.4.2 Japan
  • 9.4.3 India
  • 9.4.4 Australia
  • 9.4.5 South Korea
• 9.5 Latin America
  • 9.5.1 Brazil
  • 9.5.2 Mexico
  • 9.5.3 Argentina
• 9.6 Middle East and Africa
  • 9.6.1 South Africa
  • 9.6.2 Saudi Arabia
  • 9.6.3 UAE

Chapter 10 Company Profiles

• 10.1 ACERA SURGICAL
• 10.2 B. Braun
• 10.3 Baxter
• 10.4 Bennett
• 10.5 Biosynth
• 10.6 Cook Medical
• 10.7 DePuy Synthes
• 10.8 GUNZE
• 10.9 INTEGRA
• 10.10 Medprin
• 10.11 Medtronic
• 10.12 Natus
• 10.13 Severn Healthcare Technologies
• 10.14 Stryker
• 10.15 GORE